Neuroprotection is unlikely to be effective in humans using current trial designs: an opposing view.
Lees
Kennedy R
KR
D002986:Clinical Trials as Topic; D023381:Endpoint Determination; D006801:Humans; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D012107:Research Design; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy
D018696:Neuroprotective Agents